Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Links
Dow Jones Industrial Average
) is trading up 34 points (+0.2%) at 15,555 as of Tuesday, Jul 30, 2013, 9:35 a.m. ET. During this time, 18.7 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 583.6 million. The NYSE advances/declines ratio sits at 1,901 issues advancing vs. 669 declining with 119 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a 35-cent gain (+1.2%) bringing the stock to $29.89. This single gain is lifting the Dow Jones Industrial Average by 2.65 points or roughly accounting for 7.8% of the Dow's overall gain. Volume for Pfizer currently sits at 1.2 million shares traded vs. an average daily trading volume of 61.2 million shares.
Pfizer has a market cap of $207.52 billion and is part of the health care sector and drugs industry. Shares are up 17.8% year to date as of Monday's close. The stock's dividend yield sits at 3.3%.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Pfizer Ratings Report.
Holding back the Dow today is
), which is lagging the broader Dow index with a three-cent decline (-0.4%) bringing the stock to $8.01. Volume for Alcoa currently sits at 379,163 shares traded vs. an average daily trading volume of 16.3 million shares.
Alcoa has a market cap of $8.63 billion and is part of the basic materials sector and metals & mining industry. Shares are down 7.4% year to date as of Monday's close. The stock's dividend yield sits at 1.5%.
Alcoa Inc. engages in the production and management of primary aluminum, fabricated aluminum, and alumina. The company operates in four segments: Alumina, Primary Metals, Global Rolled Products, and Engineered Products and Solutions.
TheStreet Ratings rates Alcoa as a
. Among the primary strengths of the company is its respectable return on equity which we feel is likely to continue. At the same time, however, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and relatively poor performance when compared with the S&P 500 during the past year.
- You can view the full Alcoa Ratings Report.